News

Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.

Laurila PP, Luan P, Wohlwend M, Zanou N, Crisol B, Imamura de Lima T, Goeminne LJE, Gallart-Ayala H, Shong M, Ivanisevic J, Place N, Auwerx J. Sci Adv. 2022 Jan...

28 gennaio 2022

GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression.

Addicks GC, Zhang H, Ryu D, Vasam G, Green AE, Marshall PL, Patel S, Kang BE, Kim D, Katsyuba E, Williams EG, Renaud JM, Auwerx J, Menzies KJ. J Cell Biol. 2022 Feb...

14 gennaio 2022

Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.

Duran-Trio L, Fernandes-Pires G, Grosse J, Soro-Arnaiz I, Roux-Petronelli C, Binz PA, De Bock K, Cudalbu C, Sandi C, Braissant O. J Inherit Metab Dis. 2021 Dec 22.

22 dicembre 2021

CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.

Domenig SA, Bundschuh N, Lenardič A, Ghosh A, Kim I, Qabrati X, D'Hulst G, Bar-Nur O. Stem Cell Reports. 2021 Dec 21:S2213-6711(21)00642-1.

21 dicembre 2021

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, Attarian S, Benedetti L, Briani C, Casasnovas C, Castellani F, Dardiotis E,...

16 dicembre 2021

Acute RyR1 Ca2+ leak enhances NADH-linked mitochondrial respiratory capacity.

Zanou N, Dridi H, Reiken S, Imamura de Lima T, Donnelly C, De Marchi U, Ferrini M, Vidal J, Sittenfeld L, Feige JN, Garcia-Roves PM, Lopez-Mejia IC, Marks AR, Auwerx J,...

10 dicembre 2021

Rheological properties of skeletal muscles in a Duchenne muscular dystrophy murine model before and after autologous cell therapy.

Zemła J, Iyer PS, Pyka-Fościak G, Mermod N, Lekka M. J Biomech. 2021 Nov 9;128:110770.

09 dicembre 2021

<< Prima < Precedente 41-50 51-60 61-7071-8081-90 91-100 101-110 Prossima >Ultima >>

News

Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.

GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression.

Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.

CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.

Acute RyR1 Ca2+ leak enhances NADH-linked mitochondrial respiratory capacity.

Rheological properties of skeletal muscles in a Duchenne muscular dystrophy murine model before and after autologous cell therapy.

Exon-independent recruitment of SRSF1 is mediated by U1 snRNP stem-loop 3.

Survival and Motor Phenotypes in FVB C9-500 ALS/FTD BAC Transgenic Mice Reproduced by Multiple Labs.

Biofabrication of 3D Human Muscle Model with Vascularization and Endomysium.

La Fondazione

FSRMM